These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 3027178)

  • 21. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation.
    Pereira S; Webster D; Platts-Mills T
    Eur J Immunol; 1982 Jul; 12(7):540-6. PubMed ID: 6288397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
    J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiologic analysis of peripheral blood lymphocytes from patients with primary immunodeficiency. I. Ig synthesis by peripheral blood lymphocytes stimulated with either pokeweed mitogen or Epstein-Barr virus in vitro.
    Mitsuya H; Osaki K; Tomino S; Katsuki T; Kishimoto S
    J Immunol; 1981 Jul; 127(1):311-5. PubMed ID: 6263975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.
    Pilarski LM; Ruether BA; Mant MJ
    J Clin Invest; 1985 Jun; 75(6):2024-9. PubMed ID: 2989339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation.
    Mudde GC; van Dam D; De Gast GC
    Clin Exp Immunol; 1986 Apr; 64(1):150-7. PubMed ID: 3488148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
    van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
    Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.
    Tosato G; Magrath IT; Koski IR; Dooley NJ; Blaese RM
    J Clin Invest; 1980 Aug; 66(2):383-8. PubMed ID: 6249850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C; Zubler RH
    J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human peripheral blood mononuclear cells produce IgA anti-influenza virus antibody in a secondary in vitro antibody response.
    Yarchoan R; Barrow LA; Kurman C; Strober W; Nelson DL
    J Immunol; 1985 Aug; 135(2):1033-9. PubMed ID: 3874224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limiting dilution analysis of the B cell compartment in human bone marrow.
    Hibi T; Dosch HM
    Eur J Immunol; 1986 Feb; 16(2):139-45. PubMed ID: 2869953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies against isotypic and isoallotypic determinants of human IgA1 and IgA2: fine specificities and binding properties.
    Delacroix DL; Van Snick J; Vaerman JP; Conley ME; Mascart-Lemone F; Bernier GM
    Mol Immunol; 1986 Apr; 23(4):367-75. PubMed ID: 2425248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell-dependent differentiation of human B cells into IgM, IgG, IgA, or IgE plasma cells: high rate of antibody production by IgE plasma cells, but limited clonal expansion of IgE precursors.
    Brinkmann V; Heusser CH
    Cell Immunol; 1993 Dec; 152(2):323-32. PubMed ID: 8258141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
    Jelinek DF; Splawski JB; Lipsky PE
    J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.